BridgeMD
Compares treatment options for Coronary Artery Disease
Official title Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy
ClinicalTrials.gov ID: NCT05824520
What this study is testing
- What it's testing
- The overall purpose of ACCURATE II trial is to compare the clinical outcomes of CT-derived FFR guided strategy versus medical therapy in patients with chronic coronary syndrome.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age ≥ 18 years, with at least one vessel has CT-derived FFR≤0.80
- Patients with chronic coronary syndromes
- Signed written informed consent
You likely can't join if
- The patient has a known hypersensitivity or contraindication to any of the following medications: Heparin, Aspirin, Clopidogrel, Prasugrel...
- Prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)
- Sinus arrhythmia, cardiogenic shock, or severe heart failure (NYHA≥III)
- Inability or unwillingness to undergo CT scan or coronary angiography
- Patients on hemodialysis or with severe hepatic or renal insufficiency
- Left main coronary artery stenosis ≥ 50%
See the full eligibility criteria
- Age ≥ 18 years, with at least one vessel has CT-derived FFR≤0.80
- Patients with chronic coronary syndromes
- Signed written informed consent
- The patient has a known hypersensitivity or contraindication to any of the following medications: Heparin, Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Contrast media (Patients with documented sensitivity to contrast...
- Prior percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG)
- Sinus arrhythmia, cardiogenic shock, or severe heart failure (NYHA≥III)
- Inability or unwillingness to undergo CT scan or coronary angiography
- Patients on hemodialysis or with severe hepatic or renal insufficiency
- Left main coronary artery stenosis ≥ 50%
- Target vessel total occlusion
- Pregnancy or intention to become pregnant during the course of the trial
- Patients with a life expectancy less than 2 years
The study team makes the final eligibility decision.
Where it's taking place
- Hangzhou, Zhejiang, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hangzhou, Zhejiang, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.